Introduction
Extracorporeal carbon dioxide removal (ECCO 2 R) is a partial form of extracorporeal lung assist (ECLA), which can be used in the management of refractory hypercapnic respiratory failure. [1] It is a valid alternative to consider in hypercapnic respiratory failure in chronic obstructive pulmonary disease (COPD) patients to avoid invasive ventilation when noninvasive ventilation fails. [2] Here we report a similar case, after obtaining informed consent, where a patient suffering from severe hypercapnic respiratory failure due to COPD, was selected for ECCO 2 R and improved remarkably.
Case Report
We present a case report of a 73-year-old male (91.5 kg, height -184 cm) referred to our hospital with acute on chronic COPD exacerbation and Type 2 respiratory failure not responding to conventional nonivasive ventilation. Later patient developed multiple organ dysfunction syndrome with Type 2 respiratory failure with mixed acidosis.
His presenting blood gases showed profound acidemia. pH -7.057, base excess -7.5, PCO 2 -11.23 kPa, PaO 2 -13.7 kPa on FiO 2 -50%. P: F ratio was around 200. His inflammatory markers were high (total leukocyte count [TLC] 26 × 10 9 /L, procalcitonin 11.2 mcg/L, C-reactive protein [CRP] 104 mg/L) and renal functions worsened and he was oliguric.
He was started on appropriate antibiotics and noninvasive ventilation. He was started on noradrenaline infusion to target mean arterial pressure of 70 mm Hg. Continuous veno-venous hemodiafiltration instituted to manage his renal failure with an aim for a negative fluid balance of 1.5 L. Hemodynamic monitoring was done by pulse-induced contour cardiac output.
After 12 h, he continued to be acidotic profoundly because of raised PaCO 2 -10.86 kPa. Failure to remove CO 2 was noted despite being on non-invasive ventilation.
His chest was clear B/L on auscultation. His vasopressors
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